Dr. Philipp Schlatter
Community of Practice Leader, Post Trial Access & Drug Supply
Director, Global Medical Affairs, Early Access
Global Operations Lead - Managed Access
NYU Working Group on Compassionate Use and Preapproval Access (CUPA)
Global Head of Humanitarian Aid and Managed Access Programs
Global Medical Affairs, Senior Manager Early Access Programs
Head Global Governance Office, Chief Medical Office
Director, Patient Strategies & Solutions, Office of the Chief Medical Officer
President & CEO
Cognition Therapeutics and CUPA Member
Founding President & CEO
Parent Project Muscular Dystrophy (PPMD) and CUPA Member
Assistant Professor, Biostatistics Division, Department of Population Health
New York University School of Medicine
VP Business Development - Early Access Programs
There has never been a greater global focus on providing access to medicine, as the COVID-19 crisis brings Pre-approval programmes to the frontline in fighting epidemic outbreaks.
In-Person conferences may be currently postponed, but the Early and Managed Access Programmes Digital Summit – our digital partner to the annual London based iteration - is the perfect environment to engage with industry experts who are managing these EMAPs under Covid-19, across global markets. This year’s digital summit will join leading figures in early and managed access development will combine with patient advocacy and medical ethics experts to address challenges at the very heart of this vital yet, complex, field.
Ensure you feel secure in your next steps – during the COVID-19 crisis and beyond and join the conversation this October
"My knowledge has increased, which I can take back to my organisation"
"Good event, good networking opportunities and relationship building."